SYCN and pancreatic neoplasm: Syncollin has been identified in a qualitative proteomic analysis of pancreatic juice from patients with pancreatic cancer, and was elevated in serum from a murine model of pancreatic cancer [20,21]; however to our knowledge, this is the first report of its study and extended validation through ELISAs in human serum.